Results 101 to 110 of about 115,511 (189)

Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients

Antibiotics
Objectives: The aim of this work was to perform a systematic review assessing the pharmacokinetic/pharmacodynamic (PK/PD) properties of dalbavancin and the clinical use for in-label and off-label indications in pediatric patients.
Désirée Caselli, Maurizio Aricò, Elio Castagnola, Milo Gatti   +3 more
doaj   +1 more source

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence. [PDF]

Infect Drug Resist, 2022
Giacobbe DR, Dettori S, Corcione S, Vena A, Sepulcri C, Maraolo AE, De Rosa FG, Bassetti M.   +7 more
europepmc   +1 more source

Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. [PDF]

Eur J Health Econ, 2022
Zinzi D, Vlachaki I, Falla E, Mantopoulos T, Nathwani D.   +4 more
europepmc   +1 more source

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections

Therapeutics and Clinical Risk Management, 2012
Julian J Goodman, Stanley I MartinDivision of Infectious Diseases, The Ohio State University, Columbus, OH, USAAbstract: Ceftaroline is a novel broad-spectrum cephalosporin ß-lactam antibiotic with activity against methicillin-resistant ...
Goodman JJ, Martin SI
doaj  

Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs. [PDF]

Infect Dis Ther, 2022
Moran GJ, Chitra S, McGovern PC.
europepmc   +1 more source

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus

Therapeutics and Clinical Risk Management, 2012
Mao Hagihara1, Takumi Umemura1, Takeshi Mori1,2, Hiroshige Mikamo11Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; 2Division of Pharmaceutical Science, Faculty of Pharmacy, Meijo ...
Mori T, Umemura T, Hagihara M, Mikamo H
doaj  

The detection of bacteria and matrix proteins on clinically benign and pathologic implants [PDF]

, 2019
Adams, Adams, Albesharat, Arrecubieta, Barbieri, Bartsich, Bowden, Brown, Burkhardt, Cohen, Constantine, Deva, Deva, DiEgidio, Dolen, Drinane, Drinane, Ellis, Flores-Mireles, Flores-Mireles, Flores-Mireles, Flugstad, Galdiero, Gerlach, Giordano, Giot, Hieken, Hu, Jacombs, Jacombs, Kalas, Kane, Moser, Moyer, Paek, Paharik, Pajkos, Perez, Poppler, Prantl, Rieger, Rieger, Rosen, Sabaté Brescó, Samen, Spaulding, Tamboto, Urbaniak, Urbaniak, Walker, Wolfram, Xu, Zdolsek   +52 more
core   +2 more sources

The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials

Infection and Drug Resistance, 2019
Chih-Wei Chen,1,2 Shen-Peng Chang,3 Hui-Ting Huang,4 Hung-Jen Tang,5 Chih-Cheng Lai61Division of Neurosurgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan; 2Department of Occupational Safety and Health/Institute of Industrial Safety and
Chen CW, Chang SP, Huang HT, Tang HJ, Lai CC   +4 more
doaj  

Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study. [PDF]

Cureus, 2022
Mehta KD, Sharma JB, Anand A, Reddy N PK, Kadam P, Debnath K, Bhapkar S, Thampi BM.   +7 more
europepmc   +1 more source

Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections. [PDF]

Antimicrob Agents Chemother, 2021
Li D, Sabato PE, Guiastrennec B, Ouerdani A, Feng HP, Duval V, De Anda CS, Sears PS, Chou MZ, Hardalo C, Broyde N, Rizk ML.   +11 more
europepmc   +1 more source